Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk in Patients With Primary Hyperparathyroidism

NCT07870369 is registered in ClinicalTrials.gov with Medical University of Sofia as lead sponsor.

NCT NCT07870369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07870369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk in Patients With Primary Hyperparathyroidism
Lead sponsor
Medical University of Sofia
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
December 31, 2025
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation (af), coronary artery disease, heart failure, hypertension (htn)